- Investing Ideas
- /
- Japanese Pharmaceuticals & Biotech Big Green Snowflakes
Japanese Pharmaceuticals & Biotech Big Green Snowflakes
Results
90
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
90 companies
Precision System Science
Market Cap: JP¥5.5b
Develops, manufactures, and sells automated systems/instruments, other physicochemical instruments, software, and other products.
7707
JP¥204.00
7D
0%
1Y
10.3%
Oncolys BioPharma
Market Cap: JP¥15.5b
Engages in the research, development, manufacture, sale, import, and export of oncolytic viruses, drugs and medicines, and tumor diagnostic agents in Japan, the rest of Asia, and the United States.
4588
JP¥624.00
7D
20.9%
1Y
-5.0%
MedRx
Market Cap: JP¥2.9b
A pharmaceutical formulation development company, provides pharmaceutical drugs based on the transdermal absorption system in Japan.
4586
JP¥61.00
7D
-1.6%
1Y
-62.1%
Heartseed
Market Cap: JP¥58.7b
Develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for heart failure.
219A
JP¥2,626.00
7D
5.0%
1Y
n/a
3-D Matrix
Market Cap: JP¥16.3b
Develops self-assembling peptide technology in Japan and internationally.
7777
JP¥148.00
7D
13.0%
1Y
7.2%
PhoenixBio
Market Cap: JP¥1.6b
Provides contract study services for drug discovery and development primarily in Japan.
6190
JP¥388.00
7D
4.6%
1Y
-19.0%
Transgenic Group
Market Cap: JP¥2.6b
Develops, distributes, and licenses genetically modified animals and antibodies in Japan.
2342
JP¥159.00
7D
0.6%
1Y
-30.6%
Chiome Bioscience
Market Cap: JP¥9.9b
Engages in the research and development of drug discovery technology platforms worldwide.
4583
JP¥146.00
7D
5.0%
1Y
22.7%
Stella Pharma
Market Cap: JP¥13.0b
Engages in the research, development, manufacturing, and distribution of pharmaceuticals.
4888
JP¥383.00
7D
6.1%
1Y
14.3%
SymBio Pharmaceuticals
Market Cap: JP¥8.3b
Engages in the research and development, manufacturing, and sales of pharmaceuticals and related operations to treat cancer, hematology, and viral infectious diseases in Japan and internationally.
4582
JP¥170.00
7D
5.6%
1Y
10.4%
Nxera Pharma
Market Cap: JP¥81.6b
Develops and sells pharmaceutical products in Japan, the United States, Germany, Switzerland, Bermuda, and the United Kingdom.
4565
JP¥908.00
7D
11.0%
1Y
-37.5%
BrightPath Biotherapeutics
Market Cap: JP¥3.6b
Engages in the development of cancer immunotherapy drugs in Japan.
4594
JP¥40.00
7D
-2.4%
1Y
-31.0%
K PharmaInc
Market Cap: JP¥8.8b
Engages in the research, development, manufacture, and sale of regenerative medicines and pharmaceutical products in Japan.
4896
JP¥756.00
7D
6.8%
1Y
6.9%
PRISM BioLabLTD
Market Cap: JP¥9.9b
A biotechnology company, discovers and develops small molecule inhibitors of protein-protein interaction targets utilizing proprietary PepMetics technology for treating patients suffering from cancer, autoimmune, fibrosis, and other diseases.
206A
JP¥274.00
7D
7.5%
1Y
n/a
Wakamoto PharmaceuticalLtd
Market Cap: JP¥10.5b
Manufactures and sells ethical and non-prescription drugs in Japan.
4512
JP¥302.00
7D
2.0%
1Y
18.9%
NPTLtd
Market Cap: JP¥6.7b
Engages in clinical development of new drugs and treatments for personalized medicines.
311A
JP¥1,200.00
7D
0%
1Y
n/a
CellSeed
Market Cap: JP¥17.9b
Develops cell sheet regenerative medicines.
7776
JP¥516.00
7D
-4.4%
1Y
99.2%
MEDINET
Market Cap: JP¥7.9b
Operates as a contract development and manufacturing organization that provides regenerative medicine and cell therapy solutions in Japan.
2370
JP¥30.00
7D
0%
1Y
-33.3%